Literature DB >> 352629

Effective and ineffective immune responses to parasites: evidence from experimental models.

J H Playfair.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 352629     DOI: 10.1007/978-3-642-66956-9_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  8 in total

1.  Induction of the acute-phase protein serum amyloid P in experimental Chagas' disease.

Authors:  J Scharfstein; M A Barcinski; L L Leon
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

2.  Correlation between genetic regulation of antibody responsiveness and protective immunity induced by Plasmodium berghei vaccination.

Authors:  A M Heumann; C Stiffel; L Monjour; A Bucci; G Biozzi
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

Review 3.  Malaria: immunity and prospects for vaccination.

Authors:  M Hommel
Journal:  West J Med       Date:  1981-10

4.  Host resistance of mice to Naegleria fowleri infections.

Authors:  M F Reilly; K L White; S G Bradley
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

5.  Histopathological and immunocytochemical studies of Trypanosoma musculi infection of mice.

Authors:  K Hirokawa; Y Eishi; J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Immunoelectrophoretic analysis of erythrocytic stages of Plasmodium yoelii and P. chabaudi.

Authors:  J Carlsson; K Berzins; P Perlmann
Journal:  Z Parasitenkd       Date:  1984

7.  An immunosuppressive factor in the serum of baboons (Papio anubis) infected with Schistosoma mansoni.

Authors:  B J Cottrell; R F Sturrock; M Vanhoegaerden
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

8.  Rapid parasite multiplication rate, rather than immunosuppression, causes the death of mice infected with virulent Plasmodium yoelii.

Authors:  J R Fahey; G L Spitalny
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.